Determination of 5-fluorouracil in plasma with HPLC-tandem mass spectrometry

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1257-60. doi: 10.1080/15257770600894741.

Abstract

In this article, we describe a fast and specific method to measure 5FU with HPLC tandem-mass spectrometry. Reversed-phase HPLC was combined with electrospray ionization tandem mass spectrometry and detection was performed by multiple-reaction monitoring. Stable-isotope-labeled 5FU (1,3-15N2-5FU) was used as an internal standard. 5FU was measured within a single analytical run of 16 min with a lower limit of detection of 0.05 microM. The intra-assay variation and inter-assay variation of plasma with added 5FU (1 microM, 10 microM, 100 microM) was less then 6%. Recoveries of the added 5FU in plasma were > 97%. Analysis of the 5FU levels in plasma samples from patients with the HPLC tandem mass spectrometry method and a HPLC-UV method yielded comparable results (r2 = 0.98). Thus, HPLC with electrospray ionization tandem mass spectrometry allows the rapid analysis of 5FU levels in plasma and could, therefore, be used for therapeutic drug monitoring.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacokinetics*
  • Antineoplastic Agents / pharmacology*
  • Area Under Curve
  • Chromatography, High Pressure Liquid / methods
  • Dihydrouracil Dehydrogenase (NADP) / metabolism
  • Drug Monitoring / methods
  • Fluorouracil / pharmacokinetics*
  • Humans
  • Spectrometry, Mass, Electrospray Ionization / methods*
  • Time Factors

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil